Scientists for the first time ever developed antibodies that could block Epstein Barr virus or EBV. This is a pathogen that is estimated to infect 95 per cent of the global population. The Epstein ...
Every winter, respiratory syncytial virus sends tens of thousands of U.S. infants to the hospital, filling pediatric ICU beds with babies struggling to breathe. Monoclonal antibodies have given ...
SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...